A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events
Clinical trial NCT07729475 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07729475
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-27
- Primary completion
- 2026-12-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.